In a particularly elegant study, it was demonstrated that IFNγ pathway-mutant tumors are more sensitive to CD8+ T cell-mediated eradication due to the loss of protection by IFNγ-induced PD-L1, but become more resistant when intermixed with PD-L1-producing wildtype tumor cells (56). The gene discussed is CD274; the disease is neoplasm.